Stay updated on Surufatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a new revision indication: v3.4.2, and removed the government funding notice along with the earlier revision indication (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice at the top of the page and updated the page revision to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedMinor UI text updates were made, including the glossary toggle label, capitalization of QC criteria wording, and the site revision indicator. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 removed, representing a minor administrative update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing California, Colorado, Florida, New York, Tennessee, Texas, and Virginia. Replaced the previous per-state location subsections with the consolidated Locations section and updated Revision: v3.3.3.SummaryDifference0.7%

- Check91 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the Revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Surufatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.